Mathai Mammen's Net Worth
$29.8 Million
Who is Mathai Mammen?
Mathai Mammen has an estimated net worth of $29.8 Million. This is based on reported shares across multiple companies, which include JOHNSON & JOHNSON, THERAVANCE INC, Theravance Biopharma, Inc., and 10x Genomics, Inc..
SEC CIK
Mathai Mammen's CIK is 0001421050
Past Insider Trading and Trends
2013 was Mathai Mammen's most active year for acquiring shares with 7 total transactions. Mathai Mammen's most active month to acquire stocks was the month of January. 2013 was Mathai Mammen's most active year for disposing of shares, totalling 13 transactions. Mathai Mammen's most active month to dispose stocks was the month of January. 2022 saw Mathai Mammen paying a total of $6,425,915.04 for 65,236 shares, this is the most they've acquired in one year. In 2023 Mathai Mammen cashed out on 233,000 shares for a total of $1,743,086.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
JOHNSON & JOHNSON (JNJ) Snapshot price: $158.24
EVP, Pharm, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.65% | 4.37K |
$165.89 | -$558,385.74 | 41.93K |
Feb 14 - Feb 15
| |||
Form 4
| +15.65% | 5.08K |
$168.85 | -$394,264.75 | 37.56K |
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THERAVANCE INC (INVA) Snapshot price: $15.62
SVP, Research & Early Clin Dev
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.97% | -3.26K |
$22.76 | -$74,220.36 | 334.04K |
Aug 20
| |||
Form 4
| +9.18% | 28.36K |
—
|
—
| 337.3K |
Jun 16
| |||
Form 4
| +29.84% | 71K |
—
|
—
| 308.94K |
Jun 2
| |||
Form 4
| -9.17% | -24.03K |
$26.86 | -$613,294.38 | 237.94K |
Mar 13 - May 9
| |||
Form 4
| +16.71% | 37.5K |
—
|
—
| 261.97K |
Apr 27
| |||
Form 4
| +23.12% | 42.15K |
$14.90 | $627,997.20 | 224.47K |
Mar 6
| |||
Form 4
| -2.31% | -4.31K |
$39.98 | -$172,193.86 | 182.32K |
Feb 20
| |||
Form 4
| -15.79% | -35.00K |
$39.36 | -$1,377,688.00 | 186.62K |
Scheduled
|
Feb 14
| ||
Form 4
| -2.02% | -4.57K |
$36.40 | -$166,311.60 | 222.07K |
Nov 20
| |||
Form 4
| +7.06% | 14.94K |
$25.95 | $163,151.43 | 226.64K |
Aug 20 - Aug 21
| |||
Form 4
| -3.20% | -7.00K |
$36.51 | -$255,570.00 | 211.71K |
Scheduled
|
Jul 30
| ||
Form 4
| +2.34% | 5K |
—
|
—
| 218.71K |
Jul 24
| |||
Form 4
| +5.44% | 11.02K |
$8.54 | $94,159.40 | 213.71K |
May 29
| |||
Form 4
| -1.60% | -3.29K |
$37.01 | -$121,836.92 | 202.68K |
May 20
| |||
Form 4
| -3.29% | -7.00K |
$33.74 | -$236,164.00 | 205.98K |
Scheduled
|
Apr 30
| ||
Form 4
| -5.33% | -12.00K |
$22.12 | -$265,524.20 | 212.98K |
Scheduled
|
Feb 20
| ||
Form 4
| +2.27% | 5K |
—
|
—
| 224.98K |
Feb 7
| |||
Form 4
| +6.82% | 14.05K |
$3.10 | $44,981.00 | 219.98K |
Dec 31 - Jan 11
| |||
Form 4
| -2.31% | -4.87K |
$21.08 | -$102,743.92 | 205.93K |
Nov 20
| |||
Form 4
| +2.51% | 5.16K |
$3.10 | $15,999.10 | 210.8K |
Nov 14
| |||
Form 4
| -3.29% | -7.00K |
$21.45 | -$150,162.00 | 205.64K |
Scheduled
|
Nov 2
| ||
Form 4
| +2.41% | 5K |
—
|
—
| 212.64K |
Oct 15
| |||
Form 4
| -2.19% | -4.64K |
$27.01 | -$125,434.44 | 207.64K |
Aug 20
| |||
Form 4
| -10.54% | -25.00K |
$25.74 | -$643,460.76 | 212.28K |
Scheduled
|
Aug 13
| ||
Form 4
| -1.59% | -3.83K |
$20.33 | -$77,904.56 | 237.28K |
May 20
| |||
Form 4
| -3.89% | -9.75K |
$18.54 | -$180,709.38 | 241.12K |
Feb 20
| |||
Form 4
| +2.03% | 5K |
—
|
—
| 250.86K |
Feb 15
| |||
Form 4
| -0.91% | -2.25K |
$22.34 | -$50,265.00 | 245.86K |
Nov 20
| |||
Form 4
| +1.32% | 3.23K |
$8.53 | $27,493.13 | 248.11K |
Sep 1
| |||
Form 4
| -0.91% | -2.25K |
$17.50 | -$39,340.00 | 244.89K |
Aug 20
| |||
Form 4
| -0.90% | -2.25K |
$25.48 | -$57,202.60 | 247.14K |
May 20
| |||
Form 4
| -2.71% | -6.94K |
$22.83 | -$158,467.12 | 249.38K |
Scheduled
|
Feb 18 - Feb 20
| ||
Form 4
| +78.22% | 112.5K |
—
|
—
| 256.32K |
Feb 11
| |||
Form 4
| +7.34% | 9.84K |
$8.53 | $83,868.95 | 143.82K |
Jan 28
| |||
Form 4
| -1.85% | -2.53K |
$22.52 | -$57,020.64 | 133.99K |
Nov 20
| |||
Form 4
| +10.08% | 12.5K |
—
|
—
| 136.52K |
Oct 26
| |||
Form 4
| +5.49% | 6.45K |
$8.53 | $54,994.78 | 124.02K |
Sep 7
| |||
Form 4
| -3.62% | -4.42K |
$12.84 | -$56,701.44 | 117.57K |
Sep 1
| |||
Form 4
| -1.35% | -1.67K |
$14.00 | -$23,394.00 | 121.98K |
Aug 20
| |||
Form 4
| -1.33% | -1.67K |
$13.02 | -$21,782.46 | 123.65K |
May 20
| |||
Form 4
| -1.04% | -1.32K |
$10.22 | -$13,469.96 | 125.33K |
Feb 20
| |||
Form 4
| +24.60% | 25K |
—
|
—
| 126.64K |
Feb 10
| |||
Form 4
| -1.07% | -1.10K |
$14.04 | -$15,444.00 | 101.64K |
Nov 20
| |||
Form 4
| -1.03% | -1.07K |
$15.65 | -$16,761.15 | 102.74K |
Aug 20
| |||
Form 4
| -1.02% | -1.07K |
$14.06 | -$15,058.26 | 103.81K |
May 20
| |||
Form 4
| +54.50% | 37K |
—
|
—
| 104.89K |
Mar 20
| |||
Form 4
| -1.71% | -1.18K |
$14.87 | -$17,591.21 | 67.89K |
Feb 20
| |||
Form 4
| +18.94% | 11K |
—
|
—
| 69.07K |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.82
SVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.43% | 90K |
—
|
—
| 288.11K |
Mar 15
| |||
Form 4
| -9.10% | -19.84K |
$15.65 | -$310,558.60 | 198.11K |
Feb 20
| |||
Form 4
| -0.43% | -934.00 |
$17.17 | -$16,036.78 | 217.96K |
Nov 20
| |||
Form 4
| -0.42% | -934.00 |
$12.98 | -$12,123.32 | 218.89K |
Aug 20
| |||
Form 4
| -3.24% | -7.36K |
$13.83 | -$101,788.80 | 219.82K |
Jun 2
| |||
Form 4
| -0.30% | -673.00 |
$14.24 | -$9,583.52 | 227.18K |
May 20
| |||
Form 4
| -0.29% | -674.00 |
$19.52 | -$13,156.48 | 227.86K |
Feb 20
| |||
Form 4
| +131.94% | 130K |
—
|
—
| 228.53K |
Feb 5
| |||
Form 4
| -0.81% | -658.00 |
—
|
—
| 80.49K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
10x Genomics, Inc. (TXG) Snapshot price: $45.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.10% | 1.86K |
—
|
—
| 171.61K |
Jun 14
| |||
Form 4
| +6,083.79% | 167K |
$26.99 | -$1,511,086.40 | 169.75K |
May 11
| |||
Form 4
| +339.20% | 2.12K |
—
|
—
| 2.75K |
Jun 15
| |||
Form 4
|
∞
| 625 |
—
|
—
| 625 |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||